Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2025-12-24 @ 12:09 PM
NCT ID:
NCT04847661
Eligibility Criteria:
Inclusion Criteria:
* This study will include volunteers household contact of COVID 19 confirmed cases who attend the triage clinic in the participating centers. Included persons should be \> 18 years old and below 65 years, without any contraindications for Mefloquine usage.
Exclusion Criteria:
* • People with history of previous confirmed COVID-19 infection.
* Pregnant and lactating females.
* People with neuropsychiatric disorders: myasthenia gravis, epilepsy, psychotic disorder, schizophrenia, repeated episodes of anxiety, depression.
* People with liver cirrhosis or raised liver enzymes.
* People with arrhythmias or prolonged QT interval on EKG.
* People with a history of Quinidine-Quinine analogs allergy.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04847661
Study Brief:
Protocol Section:
NCT04847661